Key result
Coronary microvascular dysfunction is linked to ~38% lower hyperemic myocardial perfusion and distinct triacylglycerol profiles.
Why the study?
The cause of coronary microvascular dysfunction (MVD) is not understood, and specific lipidomic profiles in symptomatic non-elderly subjects with MVD have not been characterized.
Are specific plasma lipidomic profiles associated with coronary microvascular dysfunction in symptomatic patients without obstructive CAD?
Cross-Sectional (n=20)
Are specific plasma lipidomic profiles associated with coronary microvascular dysfunction in symptomatic patients without obstructive CAD?
Absolute Event Rate: 1.62% vs 2.63%
p-value: p=0.009
Symptomatic coronary microvascular dysfunction is characterized by specific plasma lipidomic profiles involving saturated long-chain fatty acid-containing acylglycerols, which may help elucidate its pathobiology.
Lipidomic shifts were associated with CMD; hypothesis-generating for pathogenesis and should not yet change practice.
Coronary microvascular dysfunction (MVD) is a syndrome of abnormal regulation of vascular tone, particularly during increased metabolic demand. While there are several risk factors for MVD, some of which are similar to those for coronary artery disease (CAD), the cause of MVD is not understood. We hypothesized that MVD in symptomatic non-elderly subjects would be characterized by specific lipidomic profiles. Subjects (n = 20) aged 35–60 years and referred for computed tomography coronary angiography (CTA) for chest pain but who lacked obstructive CAD (>50% stenosis), underwent quantitative regadenoson stress-rest myocardial contrast echocardiography (MCE) perfusion imaging for MVD assessment. The presence of MVD defined by kinetic analysis of MCE data was correlated with lipidomic profiles in plasma measured by liquid chromatography and high-resolution mass spectrometry. Nine of twenty subjects had evidence of MVD, defined by reduced hyperemic perfusion versus other subjects (beta-value 1.62 ± 0.44 vs. 2.63 ± 0.99 s−1, p = 0.009). Neither the presence of high-risk but non-obstructive CAD on CTA, nor CAD risk factors were different for those with versus without MVD. Lipidomic analysis revealed that patients with MVD had lower concentrations of long-carbon chain triacylglycerols and diacylglycerols, and higher concentrations of short-chain triacylglycerols. The diacylglycerol containing stearic and linoleic acid classified all participants correctly. We conclude that specific lipidomic plasma profiles occur in MVD involving saturated long-chain fatty acid-containing acylglycerols that are distinctly different from those in non-obstructive CAD. These patterns could be used to better characterize the pathobiology and potential treatments for this condition.
No takes yet. Share an insight, caveat, or question.
Lindner et al. (2021) conducted a cross-sectional in Coronary Microvascular Dysfunction (n=20). Coronary microvascular dysfunction vs. No coronary microvascular dysfunction was evaluated on Hyperemic perfusion (beta-value) (p=0.009). Coronary microvascular dysfunction (hyperemic perfusion 1.62 vs 2.63 s-1; p=0.009) was characterized by lower long-chain and higher short-chain triacylglycerols compared to patients without MVD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: